Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. - Test2 - elhamkhani - TriplyDB

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

http://www.wikidata.org/entity/Q30362113

about

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus Anti-infective immunoadhesins from plants.Molecular aspects of MERS-CoV.The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic.MERS-CoV spike protein: a key target for antivirals.From SARS to MERS: evidence and speculation.A review of treatment modalities for Middle East Respiratory Syndrome.A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein RNA virus reverse genetics and vaccine design.Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections Receptor recognition mechanisms of coronaviruses: a decade of structural studies.Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection Identification of the Receptor-Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1.Evaluation of candidate vaccine approaches for MERS-CoV.Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27 Swift antibodies to counter emerging viruses.Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody.A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates.Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge.Treatment strategies for Middle East respiratory syndrome coronavirus.Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection.Middle East respiratory syndrome vaccines.Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection.Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines.Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.Middle East respiratory syndrome: current status and future prospects for vaccine development.Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells.Middle East respiratory syndrome coronavirus: five years later.Potent In Vivo NK Cell-mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-bispecific and Hexavalent Broadly Neutralizing Fusion Protein.

P2860

Q26700054-237B34A4-36E0-473E-8CDA-EF040D0A20EB Q26799080-C5BCF014-3B44-4D6D-9228-C41E4F331E44 Q30234479-4CE2F9AA-614C-48C5-80C0-A5A1524917AA Q30235533-01E37C14-703D-4409-A313-0BA7EA1C6F2B Q30240139-4CA2EEE3-4F0F-4D31-BCC1-FDBB0A2A7BBE Q30244685-7F190C23-4E5C-444C-B688-E6866775FB72 Q30248209-85EBA2C4-98BA-4B85-828C-4511F986A332 Q30379384-9D00CBD1-7C95-4F0D-B8E7-9470264268D0 Q30402347-7E16282F-B7D1-411F-8837-4D888FED5122 Q33963398-0D3F2043-5C4F-46B5-A2BA-2239B71E43E2 Q34324907-DD720793-B24B-40E5-AEAD-3F47D4A0F863 Q34468689-AE5A55B7-C506-45F9-930C-9D4B13494E61 Q35019893-22806CE3-67F4-4D7D-BFA1-FA9BA2B8BE4B Q35115572-8FF6CF9D-FC9E-4AE4-9774-A40CC4DC1304 Q35865538-203A9FC8-59ED-4ECD-8EBC-E18A9D26AA70 Q35913855-9A731208-56FC-45CE-8038-D0E0821B5562 Q35917397-0A86B58F-DD41-4E6F-9354-F5D8802496E6 Q35964208-5B9A1151-4EC9-432F-8072-C997F0D86442 Q35989719-96A68AA3-1ADF-44A8-BE45-659B2C1AF850 Q35989939-AFD176F4-B992-43D4-ABD7-514C74DA01EA Q36063562-D0CAD32F-1864-4F7C-A35F-39444FFD0D54 Q36069589-BCB03BB5-D46D-49A0-9886-D3966F10A4DB Q36252666-A4DDBEA6-8C52-459D-8CA8-75FFE634C1AC Q36555622-AE914FA2-BD3C-45AF-B8E2-A6D418CAB89D Q36816625-598B5EBC-2A3E-416D-A75A-D83CC2B61192 Q37143501-CD455AA3-27B7-47AE-A194-5F1BDEF95D73 Q37169882-BF3B606F-5D1C-4711-9270-CB92E419275D Q37188934-BCC2EE88-821E-48B7-A15F-D3F081B5A962 Q37434385-7C2DEC45-4FB9-4C5A-8D66-F755C9955A89 Q37512915-917292B8-34C6-489D-9F1D-944C6F67FE2B Q37717377-4CCAFE9F-B22E-4B16-8E3C-FFCB60353474 Q38959242-8E4183A4-9241-4157-9D36-4DD6F23302CF Q38993000-0572E657-33A9-44A3-A7EE-E41CED3A61EF Q39034541-1FE10B88-03B5-41C1-82E1-E7D5ECB43285 Q39102732-081981AD-A31F-4E6C-90E4-F8905DDA5103 Q39677274-22E27FEE-6F07-42DD-A47A-09F3B20E3F30 Q40041480-AE1CD4FB-EC86-49AB-8E94-93005961A007 Q40074629-F0CBEC37-18D8-4F01-86B5-68D7B59AA442 Q40085786-3AC49E2F-258D-4371-B2F6-2B9A2EC5CFE1 Q40088787-E5B6FC08-04D9-4B30-8668-13AE0220C23A

P2860

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

http://www.wikidata.org/entity/Q30362113

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Exceptionally potent neutraliz ...... y human monoclonal antibodies.

@ast

Exceptionally potent neutraliz ...... y human monoclonal antibodies.

@en

type

label

Exceptionally potent neutraliz ...... y human monoclonal antibodies.

@ast

Exceptionally potent neutraliz ...... y human monoclonal antibodies.

@en

altLabel

Exceptionally potent neutraliz ...... by human monoclonal antibodies

@en

prefLabel

Exceptionally potent neutraliz ...... y human monoclonal antibodies.

@ast

Exceptionally potent neutraliz ...... y human monoclonal antibodies.

@en

P1433

Q30362113-F5A002B4-01D7-467E-AA9C-5CE5E95A9664

P1476

Q30362113-354B5225-5D75-4741-86E6-D5EFE551BA81

P2093

Q30362113-3B714F81-57E7-4B08-917C-C2CC5D098914

Q30362113-629ACB97-516A-4CA2-B587-3824DC080115

Q30362113-62DD8C19-C469-45A2-997C-6AA1FC46DA3A

Q30362113-6A38CBA7-E24F-4536-B2F6-ED77EAB13D36

Q30362113-8735272A-AB11-4E3F-B2DC-25E49E85769B

Q30362113-AB94F988-97B1-445A-BE0A-CB174EBAF04A

Q30362113-F568C514-7540-46B7-8DFB-7A2B12220021

Q30362113-F9269C6A-B922-4AC4-862B-90BFBD6D1A16

Q30362113-FE69E635-1DB0-40D2-82B5-ACEBDDB54CEC

P2860

Q30362113-28463663-4F56-49E7-AC30-52AB2FAB627E

Q30362113-2E7199A7-E249-4E02-A19B-9DA656BF137D

Q30362113-2EC2FD06-311F-48E6-AE4B-CA2D0889D444

Q30362113-44DC1F99-8B7B-4E30-A3C3-528F13F1BE7C

Q30362113-4825E6ED-B236-4AF9-9D25-9D2CE9CF4E7B

Q30362113-4A3F11B6-017B-4D79-B78A-34DA6548CD9E

Q30362113-4ECE6F17-D49D-48A4-893D-B7BE511C7999

Q30362113-58CEDC52-A4CC-4B15-9027-DD4B61D2552D

Q30362113-5F25CC35-9065-4655-B7CA-3CA05C1E4FAF

Q30362113-612BFA9C-0A6A-4E39-82E1-DB23895621FF

P304

Q30362113-85206FF3-0750-47FC-9A86-C9903E02BD86

P31

Q30362113-D25ED446-DD5D-4359-AB07-9B4BD7F7FBD1

P356

Q30362113-849381F6-B180-4387-895E-D65BBE2E4F33

P407

Q30362113-6D5F43E0-B3FB-4BD5-AEC5-2D200AAEE074

P433

Q30362113-FFBA124A-1ECB-4756-9697-B6A88D337393

P478

Q30362113-548CB85B-D796-465F-AEB0-A1ED37436AF8

P50

Q30362113-17358ABB-626B-4D49-8001-AC1E7465D8F9

Q30362113-5D247C15-0E87-4E08-9C11-3FDE1F066426

Q30362113-6187A5F0-CAF3-4751-BCB0-E5C87B5896ED

Q30362113-BC3AFD72-7AC8-496D-B80F-080ADCFEED98

Q30362113-F6CFDF1C-B835-4E51-BC62-FD6EB0070D95

P577

Q30362113-67CCCF46-DBDF-4A14-AD49-0C3582190F01

P698

Q30362113-65DFD95E-F012-47F6-90FB-66CE0902962A

P921

Q30362113-51135239-FFC2-4596-9A51-5A6F1AAA77CC

Q30362113-57CB8B18-F7B6-4580-9289-C870E83F973D

Q30362113-75177A72-99AC-4E0C-9026-B8D93CFE2148

P932

Q30362113-5A0306DD-BC14-47CC-9CF9-F5D67397326E

P356

P1433

Journal of Virology

P1476

Exceptionally potent neutraliz ...... by human monoclonal antibodies

@en

P2093

Bo-Jian Zheng

http://www.w3.org/2001/XMLSchema#string

Candy C Y Lau

http://www.w3.org/2001/XMLSchema#string

Dimiter S Dimitrov

http://www.w3.org/2001/XMLSchema#string

Lili Wang

http://www.w3.org/2001/XMLSchema#string

Ponraj Prabakaran

http://www.w3.org/2001/XMLSchema#string

Qi Liu

http://www.w3.org/2001/XMLSchema#string

Tina W Ju

http://www.w3.org/2001/XMLSchema#string

Yang Feng

http://www.w3.org/2001/XMLSchema#string

Yanping Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies

A decade after SARS: strategies for controlling emerging coronaviruses

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development.

Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Hospital outbreak of Middle East respiratory syndrome coronavirus.

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

P304

7796-7805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00912-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24789777

http://www.w3.org/2001/XMLSchema#string

P921

Middle East respiratory syndrome coronavirus

P932

4097770

http://www.w3.org/2001/XMLSchema#string